Adherence to Anti-Viral Treatment for Chronic Hepatitis B.
Arab Bedouin
Hepatitis B virus
adherence
medication monitoring
southern Israel
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
19 Jun 2020
19 Jun 2020
Historique:
received:
19
05
2020
revised:
06
06
2020
accepted:
15
06
2020
entrez:
25
6
2020
pubmed:
25
6
2020
medline:
25
6
2020
Statut:
epublish
Résumé
Adherence to treatment of chronic Hepatitis B Virus (HBV) is an important issue and can affect the complication rate. Nucleos(t)ide analogue as oral treatments are used for patients with necro-inflammatory activity and high viral load, with the goal of decline the complication rate such cirrhosis and hepatic cancer. We aimed to investigate the adherence to chronic HBV treatment. Chronic HBV patients with dispensing medication rates (DMR) of at least 80% were defined as high adherence group (HAG) and those who dispensed less than 80% as low adherence group (LAG). The study included 273 patients. 90 patients (33%) were in the LAG and 183 (67%) in the HAG. The All-cause mortality in the LAG was 15.6%, and 8.7% among the HAG (
Identifiants
pubmed: 32575498
pii: jcm9061922
doi: 10.3390/jcm9061922
pmc: PMC7355488
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Lancet. 2015 Oct 17;386(10003):1546-55
pubmed: 26231459
Dig Liver Dis. 2015 Jul;47(7):577-83
pubmed: 25936691
Am J Gastroenterol. 2018 Jul;113(7):998-1008
pubmed: 29880971
Ann Hepatol. 2013 May-Jun;12(3):380-91
pubmed: 23619254
Hepatol Commun. 2018 Sep 25;2(10):1160-1167
pubmed: 30288470
N Engl J Med. 2004 Mar 11;350(11):1118-29
pubmed: 15014185
Hepatology. 2007 Apr;45(4):1056-75
pubmed: 17393513
Hepatology. 2013 Nov;58(5):1537-47
pubmed: 23389810
J Hepatol. 2011 Jan;54(1):12-8
pubmed: 20888661
Prev Cardiol. 2007 Fall;10(4):190-5
pubmed: 17917515
Liver Int. 2016 Sep;36(9):1239-51
pubmed: 27062182
J Health Care Poor Underserved. 2003 Nov;14(4):566-87
pubmed: 14619556
Lancet Infect Dis. 2016 Dec;16(12):1399-1408
pubmed: 27638356
J Hepatol. 2001 Apr;34(4):593-602
pubmed: 11394661
Am J Hypertens. 1995 Feb;8(2):206-9
pubmed: 7755952
Aliment Pharmacol Ther. 2008 Nov 1;28(9):1067-77
pubmed: 18657133
Antivir Ther. 2018;23(5):425-433
pubmed: 29355830
N Engl J Med. 2004 Oct 7;351(15):1521-31
pubmed: 15470215
Isr Med Assoc J. 2013 Jan;15(1):17-22
pubmed: 23484233
Fam Pract. 2004 Apr;21(2):125-30
pubmed: 15020377
Harefuah. 2012 Dec;151(12):671-4, 722, 721
pubmed: 23330257
Isr Med Assoc J. 2007 Sep;9(9):652-5
pubmed: 17939626
J Hepatol. 2010 Aug;53(2):348-56
pubmed: 20483498